Fernandez-Ramos D, Lopitz-Otsoa F, Lu S, Mato J
Cancers (Basel). 2025; 17(3).
PMID: 39941901
PMC: 11816870.
DOI: 10.3390/cancers17030535.
Yin W, Xu H, Bai Z, Wu Y, Zhang Y, Liu R
Nat Commun. 2025; 16(1):598.
PMID: 39799115
PMC: 11724923.
DOI: 10.1038/s41467-025-55939-2.
Banerjee G, Papri S, Huang H, Satapathy S, Banerjee P
Sci Data. 2025; 12(1):39.
PMID: 39788961
PMC: 11717916.
DOI: 10.1038/s41597-024-04153-8.
Sakaguchi T, Nagahama Y, Hamada N, Singh S, Mikami H, Maeda K
Nutrients. 2024; 16(23).
PMID: 39683544
PMC: 11643772.
DOI: 10.3390/nu16234151.
Xia J, Yin S, Yu J, Wang J, Jin X, Wang Y
Nutrients. 2024; 16(21).
PMID: 39519588
PMC: 11547733.
DOI: 10.3390/nu16213755.
Progress in the Study of Animal Models of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Fu Y, Hua Y, Alam N, Liu E
Nutrients. 2024; 16(18).
PMID: 39339720
PMC: 11435380.
DOI: 10.3390/nu16183120.
Serum Phosphatidylcholine Species 32:0 as a Biomarker for Liver Cirrhosis Pre- and Post-Hepatitis C Virus Clearance.
Weigand K, Peschel G, Grimm J, Horing M, Krautbauer S, Liebisch G
Int J Mol Sci. 2024; 25(15).
PMID: 39125730
PMC: 11311844.
DOI: 10.3390/ijms25158161.
Investigating the tamoxifen/high-fat diet synergy: a promising paradigm for nonalcoholic steatohepatitis induction in a rat model.
Ezz-Eldin Y, Ewees M, Azouz A, Khalaf M
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):9067-9079.
PMID: 38884676
PMC: 11522070.
DOI: 10.1007/s00210-024-03192-7.
The impact of stress on the behavior of C57BL/6 mice with liver injury: a comparative study.
Musat M, Mitran S, Udristoiu I, Albu C, Catalin B
Front Behav Neurosci. 2024; 18:1358964.
PMID: 38510829
PMC: 10950904.
DOI: 10.3389/fnbeh.2024.1358964.
The dynamic equilibrium between the protective and toxic effects of matrine in the development of liver injury: a systematic review and meta-analysis.
Feng W, Kao T, Jiang J, Zeng X, Chen S, Zeng J
Front Pharmacol. 2024; 15:1315584.
PMID: 38348397
PMC: 10859759.
DOI: 10.3389/fphar.2024.1315584.
Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice.
Westmark P, Lyon G, Gutierrez A, Boeck B, Van Hammond O, Ripp N
Nutrients. 2024; 16(2).
PMID: 38257177
PMC: 10819477.
DOI: 10.3390/nu16020284.
Characterization of a model to induce hyperlipidemia in feed-restricted dairy cows.
Arshad U, Santos J
JDS Commun. 2024; 5(1):77-82.
PMID: 38223375
PMC: 10785251.
DOI: 10.3168/jdsc.2023-0396.
Decreased FXR Agonism in the Bile Acid Pool Is Associated with Impaired FXR Signaling in a Pig Model of Pediatric NAFLD.
Maj M, Burrin D, Manjarin R
Biomedicines. 2023; 11(12).
PMID: 38137523
PMC: 10740974.
DOI: 10.3390/biomedicines11123303.
Hyperpolarized [1- C] pyruvate MRSI to detect metabolic changes in liver in a methionine and choline-deficient diet rat model of fatty liver disease.
Piraquive Agudelo J, Kim Y, Agarwal S, Sriram R, Bok R, Kurhanewicz J
Magn Reson Med. 2023; 91(4):1625-1636.
PMID: 38115605
PMC: 11032123.
DOI: 10.1002/mrm.29954.
Naringenin prevents non-alcoholic steatohepatitis by modulating the host metabolome and intestinal microbiome in MCD diet-fed mice.
Cao P, Yue M, Cheng Y, Sullivan M, Chen W, Yu H
Food Sci Nutr. 2023; 11(12):7826-7840.
PMID: 38107095
PMC: 10724642.
DOI: 10.1002/fsn3.3700.
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.
Sawada K, Chung H, Softic S, Moreno-Fernandez M, Divanovic S
Cell Metab. 2023; 35(11):1852-1871.
PMID: 37939656
PMC: 10680147.
DOI: 10.1016/j.cmet.2023.10.009.
Deletion of hepatic small heterodimer partner ameliorates development of nonalcoholic steatohepatitis in mice.
Lee Y, Park J, Lee M, Mifflin R, Xu Y, Novak R
J Lipid Res. 2023; 64(11):100454.
PMID: 37827334
PMC: 10665942.
DOI: 10.1016/j.jlr.2023.100454.
One Carbon Metabolism and -Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes.
Fernandez-Ramos D, Lopitz-Otsoa F, Millet O, Alonso C, Lu S, Mato J
Livers. 2023; 2(4):243-257.
PMID: 37123053
PMC: 10137169.
DOI: 10.3390/livers2040020.
The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism.
Harada S, Taketomi Y, Aiba T, Kawaguchi M, Hirabayashi T, Uranbileg B
Biomolecules. 2023; 13(3).
PMID: 36979406
PMC: 10046082.
DOI: 10.3390/biom13030471.
Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease.
Oates J, Sawada K, Giles D, Alarcon P, Damen M, Szabo S
Front Immunol. 2023; 14:1095132.
PMID: 36875069
PMC: 9982161.
DOI: 10.3389/fimmu.2023.1095132.